Skip to Content


In the US, Lopid (gemfibrozil systemic) is a member of the drug class fibric acid derivatives and is used to treat High Cholesterol, Hyperlipoproteinemia, Hyperlipoproteinemia Type IIb - Elevated LDL VLDL, Hyperlipoproteinemia Type IV - Elevated VLDL and Hyperlipoproteinemia Type V - Elevated Chylomicrons VLDL.

US matches:

UK matches:

Ingredient matches for Lopid


Gemfibrozil is reported as an ingredient of Lopid in the following countries:

  • Argentina
  • Australia
  • Bahrain
  • Brazil
  • Canada
  • Chile
  • Denmark
  • Ecuador
  • Egypt
  • Finland
  • Greece
  • Hong Kong
  • Iceland
  • Indonesia
  • Ireland
  • Italy
  • Lebanon
  • Netherlands
  • Oman
  • Peru
  • Philippines
  • Portugal
  • South Africa
  • Spain
  • Sweden
  • Taiwan
  • Turkey
  • United Kingdom
  • United States
  • Vietnam

Important Notice: The international database is in BETA release. This means it is still under development and may contain inaccuracies. It is not intended as a substitute for the expertise and judgement of your physician, pharmacist or other healthcare professional. It should not be construed to indicate that the use of any medication in any country is safe, appropriate or effective for you. Consult with your healthcare professional before taking any medication.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.